betaxolol has been researched along with Cranial Nerve II Diseases in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this prospective randomized double-masked comparative case series, 34 patients having LASIK for myopia were randomly assigned to receive topical betaxolol 0." | 5.10 | Effect of laser in situ keratomileusis on optic nerve head topography and retinal nerve fiber layer thickness. ( Bowman, RW; Cavanagh, HD; Hertzog, L; McCulley, JP; Song, J; Whitson, JT, 2003) |
| "Four hundred sixteen subjects with ocular hypertension (intraocular pressure >/=22 and | 2.75 | The ability of short-wavelength automated perimetry to predict conversion to glaucoma. ( Colen, TP; Lemij, HG; Reus, NJ; van der Schoot, J, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Öhnell, H | 1 |
| Heijl, A | 3 |
| Brenner, L | 1 |
| Anderson, H | 1 |
| Bengtsson, B | 3 |
| Leske, MC | 2 |
| Yang, Z | 2 |
| van der Schoot, J | 1 |
| Reus, NJ | 1 |
| Colen, TP | 1 |
| Lemij, HG | 1 |
| Vainio-Jylhä, E | 1 |
| Vuori, ML | 1 |
| Nummelin, K | 1 |
| Whitson, JT | 1 |
| McCulley, JP | 1 |
| Cavanagh, HD | 1 |
| Song, J | 1 |
| Bowman, RW | 1 |
| Hertzog, L | 1 |
| Hyman, L | 1 |
| Dong, L | 1 |
| Morrison, JC | 1 |
| Nylander, KB | 1 |
| Lauer, AK | 1 |
| Cepurna, WO | 1 |
| Johnson, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Optical Coherence Tomography Angiography Analysis of Macular and Papillary Perfusion After Variable Refractive Surgery Methods in Myopic Patients[NCT04424069] | 100 participants (Anticipated) | Interventional | 2020-03-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 trials available for betaxolol and Cranial Nerve II Diseases
| Article | Year |
|---|---|
Structural and Functional Progression in the Early Manifest Glaucoma Trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Betaxolol; Combined Modality Therapy; Diagnostic Techn | 2016 |
Disc hemorrhages and treatment in the early manifest glaucoma trial.
Topics: Adrenergic beta-Antagonists; Betaxolol; Combined Modality Therapy; Disease Progression; Follow-Up St | 2008 |
The ability of short-wavelength automated perimetry to predict conversion to glaucoma.
Topics: Aged; Antihypertensive Agents; Betaxolol; Double-Blind Method; Female; Follow-Up Studies; Glaucoma; | 2010 |
Progression of retinal nerve fibre layer damage in betaxolol- and timolol-treated glaucoma patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Betaxolol; Disease Progression; Double-Blind Method; Femal | 2002 |
Effect of laser in situ keratomileusis on optic nerve head topography and retinal nerve fiber layer thickness.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Betaxolol; Cytoprotection; Double-Blind Method; Female; Hu | 2003 |
Predictors of long-term progression in the early manifest glaucoma trial.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Betaxolol; Blood Pressure; Cardiovascular Diseases | 2007 |
1 other study available for betaxolol and Cranial Nerve II Diseases
| Article | Year |
|---|---|
Glaucoma drops control intraocular pressure and protect optic nerves in a rat model of glaucoma.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Betaxolol; Clonidine; Disease Model | 1998 |